CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF)
CUSIP: G1933S101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Ordinary Shares
- Shares outstanding
- 35,821,764
- Total 13F shares
- 449,838
- Share change
- -479,914
- Total reported value
- $1,124,376
- Price per share
- $2.50
- Number of holders
- 18
- Value change
- -$1,180,810
- Number of buys
- 5
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP G1933S101?
CUSIP G1933S101 identifies CASIF - CASI Pharmaceuticals, Inc. - Ordinary Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G1933S101:
Institutional Holders of CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) as of Q2 2023
As of 30 Jun 2023,
CASI Pharmaceuticals, Inc. - Ordinary Shares (CASIF) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
449,838 shares.
The largest 10 holders included
Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, VANGUARD GROUP INC, JANE STREET GROUP, LLC, FRANKLIN RESOURCES INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
19
Q2 2023 holders
18
Holder diff
-1
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.